ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0991

Pathogenic, Glycolytic PD-1+ B Cells Accumulate in the Hypoxic RA Joint

Achilleas Floudas1, Nuno Neto2, Viviana Marzaioli3, Kieran Murray4, Barry Moran5, Michael Monaghan6, Candice Low7, Ronan Mullan8, Navin Rao9, Vinod Krishna9, Sunil Nagpal10, Douglas Veale11 and Ursula Fearon3, 1Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Dublin, Ireland, 2Department of Mechanical and Manufacturing Engineering, Dublin, Dublin, Ireland, 3Molecular Rheumatology, Trinity College Dublin, Dublin, Dublin, Ireland, 4Saint Vincent's University Hospital, Dublin 4, Dublin, Ireland, 5Trinity Biomedical Sciences Institute, Dublin, Ireland, 6Department of Mechanical and Manufacturing Engineering, Dublin, Ireland, 7EULAR Centre for Arthritis and Rheumatic diseases, St Vincents University Hospital, UCD, Dublin, Ireland, 8Adelaide and Meath Hospital, Dublin, Dublin, Ireland, 9Janssen R&D, Spring House, PA, 10Janssen Research & Development, Collegeville, PA, 11EULAR Centre for Arthritis and Rheumatic Diseases, St Vincents University Hospital, UCD, Dublin, Dublin, Ireland

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, B-Cell Targets, hypoxia, metabolomics, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) often has a progressive and debilitating course, with significant impact on the patient’s quality of life. Despite the long-known association with autoantibodies, knowledge of the role of B cells and their potential direct contribution to RA pathogenesis remains elusive.

Characterization of B cell subpopulations in the periphery and synovial tissue.

Identification of chemokine receptors responsible for the synovial accumulation of B cells.

Characterization of B cell function and metabolism under the hypoxic conditions of the RA joint.

Methods: Synovial tissue biopsies from RA patients were obtained through key-hole arthroscopy followed by single cell flow cytometric analysis of B cell subpopulations and chemokine receptor expression. SPICE analysis was performed for the chemokine receptor expression of synovial B cells and B cell invasion assays. Functional characterization of sorted RA B cells, cultured in vitro under hypoxia, simulating the inflamed joint environment. Characterization of B cell metabolism and transcriptional regulation of pSTAT3 by flow cytometry. Notably, novel, non-invasive Fluorescent Lifetime Imaging Microscopy (FLIM) assay for the characterisation of the metabolic status of sorted RA patient PD-1 B cells coupled with RNAseq analysis was performed.

Results: Extensive flow-cytometric characterisation and SPICE algorithm analyses of single-cell synovial tissue from RA-patients revealed the accumulation of switched and double negative memory PD-1 expressing B cells at the site of inflammation. Accumulation of memory B cells is mediated by CXCR3, evident by the observed increase in CXCR3 expressing synovial B cells compared to the periphery, differential regulation by key synovial cytokines, and restricted B cell invasion demonstrated in response to CXCR3 blockade. Notably, under 3% O2 hypoxic conditions that mimic the joint-microenvironment, RA B cells maintain marked expression of MMP-9,-TNF and IL-6, with PD-1+ B-cells demonstrating higher expression of CXCR3, CD80, CD86, IL-1β and GMCSF than their PD-1– counterparts. Following functional analysis and flow cell sorting of RA PD-1+ vs PD-1– B-cells, we demonstrate using RNAseq and novel FLIM visualisation of cellular NADH, a significant shift in metabolism of RA PD-1+ B-cells towards glycolysis, associated with an increased transcriptional signature of key cytokines and chemokines that are strongly implicated in RA pathogenesis.

Conclusion: Highly polyfunctional pro-inflammatory T cell responses pre-date disease onset as demonstrated by the accumulation of polyfunctional T cells in the synovial tissue of pre-RA arthralgia subjects. These data highlight a key early pathogenic role for T cell plasticity and specific synovial T cell clusters including, DP T cells in RA.


Disclosure: A. Floudas, None; N. Neto, None; V. Marzaioli, None; K. Murray, None; B. Moran, None; M. Monaghan, None; C. Low, None; R. Mullan, None; N. Rao, Janssen R&D, 1; V. Krishna, None; S. Nagpal, None; D. Veale, AbbVie, 2, Health Beacon, 1, Janssen, 2, 8, Pfizer, 2, 5, 8, Novartis, 2, 5, 8, UCB, 2, 5; U. Fearon, None.

To cite this abstract in AMA style:

Floudas A, Neto N, Marzaioli V, Murray K, Moran B, Monaghan M, Low C, Mullan R, Rao N, Krishna V, Nagpal S, Veale D, Fearon U. Pathogenic, Glycolytic PD-1+ B Cells Accumulate in the Hypoxic RA Joint [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/pathogenic-glycolytic-pd-1-b-cells-accumulate-in-the-hypoxic-ra-joint/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pathogenic-glycolytic-pd-1-b-cells-accumulate-in-the-hypoxic-ra-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology